Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | ATR | Q13535 | 2/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869099 | 0.82 | ATR (0.36) | RXRARXRBRXRGATR | |
| SCHEMBL30869064 | 0.79 | ATR (0.41) | ATR | |
| SCHEMBL30797857 | 0.79 | ATR (0.41) | RXRARXRBRXRGATR | |
| SCHEMBL30797974 | 0.78 | ATR (0.44) | RXRARXRBRXRGATR | |
| SCHEMBL30797547 | 0.77 | ATR (0.42) | RXRARXRBRXRGATR | |
| SCHEMBL30797980 | 0.77 | ATR (0.49) | RXRARXRBRXRGATR | |
| SCHEMBL30797688 | 0.76 | ATR (0.44) | RXRARXRBRXRGATR | |
| SCHEMBL30798114 | 0.76 | ATR (0.42) | RXRARXRBRXRGATR | |
| SCHEMBL30797751 | 0.76 | BRD4 (0.46) | RXRARXRBRXRGATR | |
| SCHEMBL27377168 | 0.75 | ATR (0.41) | RXRARXRBRXRGATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |